Clopidogrel and Hepatitis b - a phase IV clinical study of FDA data

Summary:

Hepatitis b is reported as a side effect among people who take Clopidogrel (clopidogrel), especially for people who are female, 60+ old, also take Aranesp, and have Essential thrombocythaemia.

The phase IV clinical study analyzes which people have Hepatitis b when taking Clopidogrel. It is created by eHealthMe based on reports of 91,038 people who have side effects when taking Clopidogrel from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Hepatitis b?

Hepatitis b is found to be associated with 517 drugs and 683 conditions by eHealthMe. Check the latest studies of Hepatitis b.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

91,038 people reported to have side effects when taking Clopidogrel.
Among them, 29 people (0.03%) have Hepatitis b.

Among these 29 people:

What is the gender of people who have Hepatitis b when taking Clopidogrel? *

female: 70 %
male: 30 %

What is the age of people who have Hepatitis b when taking Clopidogrel? *

What are other drugs people take besides Clopidogrel? *

What are other side effects people have besides Hepatitis b? *

Anaemia (lack of blood): 12 people, 41.38%
Enterococcal Infection: 7 people, 24.14%
Depression: 7 people, 24.14%
Pain In Extremity: 7 people, 24.14%
Fatigue (feeling of tiredness): 7 people, 24.14%
Pneumonia: 7 people, 24.14%
Dyspnea (difficult or laboured breathing): 7 people, 24.14%
Nausea (feeling of having an urge to vomit): 7 people, 24.14%
Cytomegalovirus Infection: 7 people, 24.14%
Dizziness: 6 people, 20.69%

What are the existing conditions these people have? *

Essential Thrombocythaemia (chronic blood cancer): 12 people, 41.38%
High Blood Pressure: 8 people, 27.59%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 20.69%
Insomnia (sleeplessness): 6 people, 20.69%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 20.69%
Carotid Artery Disease: 6 people, 20.69%
Constipation: 6 people, 20.69%
Depression: 6 people, 20.69%
Diabetes: 6 people, 20.69%
Dry Eyes (lack of adequate tears): 6 people, 20.69%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and have Hepatitis b?

- Check whether Hepatitis b is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopidogrel:

Clopidogrel (92,160 reports)

Hepatitis b treatments and more:

Hepatitis b (21,088 reports)

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis b:

Hepatitis b (517 drugs)

Browse all the conditions that are associated with Hepatitis b:

Hepatitis b (683 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel (the active ingredients of Clopidogrel) and Clopidogrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.